Couldn‘t find the right answer?
Send us your question!
Regenerates the cervical mucosa and restores
equilibrium of the vaginal flora
Papilocare® is a re-epithelialising vaginal gel for the preventive and supportive treatment of lesions caused by HPV (ASCUS/LSIL).
The vaginal gel regenerates the cells and restores an
optimal balance of the vaginal flora.
Clinical studies show both a positive effect upon direct treatment of lesions caused by HPV (ASCUS/LSIL) and a preventive effect within 6 months.
More deatailed information about
Papilocare® is available for download here:
Papilocare® is available without prescription from all pharmacies and online pharmacies.
Health insurance schemes generally do not reimburse the costs for this treatment, which have thus to be borne by the purchaser.
Infections with the human papillomavirus (HPV) are among the most common sexually transmitted diseases. A differentiation is made between harmless genital warts and serious (tumorous) disease in the genital tract, anus or throat area.
Decades may pass before cancer develops, as various precancerous stages develop first.
Use of Papilocare® is recommended as precautionary medicine for women (over 18 years), who have been infected with the human papilloma virus (HPV) or already have lesions caused by the virus (ASCUS or LSIL).
|Insert the tube into the
vagina when in a lying position,
preferably before bedtime.
|Press the tube to apply the gel into the
inside of the vagina.
|Then remove the tube carefully from the
vagina and dispose of the container.
For information about risks and side-effects, read the dabeipackzettel or ask your doctor or pharmacist